Keywords: MMA; Methylmalonic acidemia; PA; Propionic acidemia; αFP; alpha-fetoprotein; ID; intellectual disability; IQ; intelligence quotient; GH; growth hormone; GGT; gamma-glutamyltranspeptidase; GFR; glomerular filtration rate; MRI; magnetic resonance imaging;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Lysyl oxidase (LOX); Lower grade gliomas (LGGs); Biomarker; TCGA; EMT; IDH1;
Keywords: Cancer metabolism; Combinatory therapy; Glutaminase isoenzymes; Glutamine; Glutaminase inhibitors; Metabolic reprogramming; DON; 6-diazo-5-oxy-L-norleucine; EATC; Ehrlich ascites tumour cells; ERK; extracellular signal-regulated kinases; GA; glutaminase;
Keywords: GBM; Glioblastoma multiforme; CARs; chimeric antigen receptors; PDL1; programmed death ligand 1; IDH1; isocitrate dehydrogenase 1; PMN; polymorphonuclear; TAMs; tumor associated macrophages; HLA; human leucocyte antigen; FLT3L; Fms-like tyrosine kinase 3
Keywords: Aqueduct; Tectum; ETV; BRAF V600E; IDH1;
Keywords: SLC25A1; Citrate transporter; 2HG; IDH1; Lung cancer; Cancer metabolism;
Keywords: IDH1 mutation (R132H); Predictive scoring system; Prognostic factors; Secondary glioblastoma (sGBM); IDH1; Isocitrate dehydrogenase-1; MRI; Magnetic resonance imaging; OS; Overall survival; sGBM; Secondary glioblastoma; WHO; World Health Organization;
Keywords: Glioma; Glioblastoma; IDH1; 1p/19q codeletion; Genomics; TERT; ATRX
Keywords: DESI, mass spectrometric imaging; MALDI; Margin assessment; Mass spectrometry; REIMS; Metabolic fingerprint; Surgery; Intraoperative; Cancer; 2-HG; 2-hydroxyglutarate; CBS-MS; coated blade spray mass spectrometry; CT; computed tomography; CUSA; Cavitron u
Keywords: GLS; glutaminase; GDH; glutamate dehydrogenase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; TCA; tricarboxylic acid cycle; SS; succinylCoA synthetase; ME; malic enzyme; IDH1; isocytrate dehydrogenase; AARE; aminoacid responsive element
Keywords: Îp; proton motive force established on inner mitochondrial membrane; ÎÏ; electrical membrane potential established on inner mitochondrial membrane; COX4.1; cytochrome c oxidase subunit 4 isoform 1; ERK; extracellular signal-regulated kinase; FA; fatty
Keywords: 1p19q; Anaplastic gliomas; IDH1; MGMT; Prognosis; Recurrence; Temozolomide
Keywords: Astrocytoma; Ganglioglioma; Low-grade glioma; Multicentric glioma; Platelet-derived growth factor receptor amplification; Tumor progression; IDH1; Isocitrate dehydrogenase 1; LGG; Low-grade glioma; MRI; Magnetic resonance imaging; PDGFRA/B; Platelet-deriv
Keywords: Copy number variation; IDH1; IDH2; Maffucci syndrome; Microarray analysis
Keywords: Astrocytoma; IDH1; Outcomes; SurgeryAII, WHO grade II astrocytomas; ECOG, Eastern Cooperative Oncology Group; IDH1, Isocitrate dehydrogenase 1; MRI, Magnetic resonance imaging; OS, Overall survival; PFS, Progression-free survival; WHO, World Health Organi
Keywords: Glioblastoma; Treatment; Review; Pharmacology; Targeted therapy; Stem cell; AKT; protein kinase B; BBB; blood-brain barrier; BCNU; carmustin; CCNU; lomustin; c-MET; hepatocyte growth factor receptor; EGF(R); epidermal growth factor (receptor); EGFRvIII; e
Keywords: α-KG; alpha-ketoglutarate; 2-HG; 2-hydroxyglutarate; 5hmC; 5-hydroxymethylcytosine; 5mC; 5-methylcytosine; AML; acute myeloid leukemia; ASXL1; additional sex combs-like 1; AZA; azacytidine; CMML; chronic myelomonocytic leukemia; DAC; decitabine; DNMT3A;
Keywords: AAV; adeno-associated virus; Aex; ascites-derived exosomes; BACE1; beta secretase 1; BAP-TM; biotin acceptor peptide-transmembrane domain; CAM; cell adhesion molecule; CD; cluster of differentiation; CD; cytosine deaminase; Dex; dendritic cell-derived exo
Keywords: ÎKG; α-ketoglutarate; AML; acute myeloid leukemia; BCAT1; branched-chain amino acid transporter 1; BRD4; bromodomain-containing protein 4; D-2HG; D-2-hydroxyglutarate or R-2-hydroxyglutarate; D-2HGA; D-2-hydroxyglutarate aciduria; D2HGDH; D-2-hydroxyglu
Keywords: Melanoma; IDH1; Isocitrate dehydrogenase; Uveal melanoma; Ophthalmic pathology
Cholangiocarcinoma
Keywords: Cholangiocarcinoma; Bile duct; Intrahepatic; Extrahepatic; IDH1; IDH2;
Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival
Keywords: Glioblastoma; Glioma; Magnetic Resonance Imaging; FLAIR; IDH1;
The post-surgical era of GBM: How molecular biology has impacted on our clinical management. A review
Keywords: Glioblastoma; MGMT; IDH1; IDH2; TERT; BRAF; High grade gliomas; Molecular biology;
Correlation of IDH1 and B7H3 expression with prognosis of CRC patients
Keywords: B7H3; Colorectal cancer; IDH1; Immunity; Metabolism; Survival analysis;
IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy
Keywords: Glioma; IDH1; Seizure; Epilepsy; Tumor;
Steroids from Ganoderma sinense as new natural inhibitors of cancer-associated mutant IDH1
Keywords: IDH1; Steroids; Ganoderma sinense; Virtual ligand screening, Cancer; IDH1; isocitrate dehydrogenase; MST; microscale thermophoresis; CCK8; cell counting Kit-8; IPTG; isopropyl β-D-1-thiogalactopyranoside; PMSF; phenylmethanesulfonyluoride; PVDF; polyviny
IDH1 mutation correlates with a beneficial prognosis and suppresses tumor growth in IHCC
Keywords: Intrahepatic cholangiocarcinoma; IDH1; Tumor growth; Akt; SC79;
Liponeurocytoma: Systematic Review of a Rare Entity
Keywords: Adjuvant radiotherapy; Liponeurocytoma; Recurrence; Surgery; Systematic review; CT; Computed tomography; DWI; Diffusion-weighted imaging; FLAIR; Fluid-attenuated inversion recovery; FDG; [18F]fluorodeoxyglucose; IDH1; Isocitrate dehydrogenase 1; MRI; Magn
Epigenetics in myelodysplastic syndromes
Keywords: MDS; Epigenetics; ASXL1; DNMT3A; EP300; EZH2; IDH1; IDH2; KDM2B; KDM5A; KDM6A; MLL; MLL2; MLL3; MLL5; TET2; WT1; Hypomethylating agent; HDAC inhibitor;
High Expression of Glypican-1 Predicts Dissemination and Poor Prognosis in Glioblastomas
Keywords: Dissemination; Glioblastoma; Glypican-1; Prognosis; Radiotherapy; Temozolomide; ANX2A; Annexin 2A; GBM; Glioblastoma; GPC-1; Glypican-1; GPI; Glycosyl-phosphatidylinositol; HR; Hazard ratio; IDH1; Isocitrate dehydrogenase 1; KPS; Karnofsky performance sta
Original contributionDiagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone
Keywords: IDH1; IDH2; Dedifferentiated chondrosarcoma; Undifferentiated pleomorphic sarcoma (UPS) of bone;
Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis
Keywords: Gliomatosis cerebri; Overall survival; SEER; AA; Anaplastic astrocytoma; GC; Gliomatosis cerebri; HR; Hazard ratio; ICD-O-3; International Classification of Disease for Oncology, Third edition; IDH1; Isocitrate dehydrogenase 1; RT; Radiation therapy; SEER
Impact of Resection on Survival of Isocitrate Dehydrogenase 1-Mutated World Health Organization Grade II Astrocytoma After Malignant Progression
Keywords: Low-grade glioma; Malignant progression; Resection; Survival; CI; Confidence interval; GTR; Gross total resection; IDH1; Isocitrate dehydrogenase 1; KPS; Karnofsky Performance Status; MRI; Magnetic resonance imaging; OS; Overall survival; PCR; Polymerase
Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results
Keywords: Gliomas; Glioblastoma; Oligodendroglioma; Astrocytoma; 1p/19q; ATRX; IDH1;
NF-κB controls four genes encoding core enzymes of tricarboxylic acid cycle
Keywords: NF-κB; Nuclear factor-κB; TF; transcription factor; ChIP-Seq; chromatin immunoprecipitation followed by deep sequencing; BSs; binding sites; TCA; tricarboxylic acid; ChIP-PCR; chromatin immunoprecipitation followed by polymerase chain reaction; RHD; rel
IDH1/2 gene hotspot mutations in central nervous system tumours: analysis of 922 Chinese patients
Keywords: Central nervous system tumours; IDH1; IDH2; immunohistochemistry; mutation; sequencing; survival analysis;
R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling
Keywords: Mutant IDH1-R132H; β-Catenin; Glioma; Proliferation; Invasion; IDH1; isocitrate dehydrogenase 1; WHO; World Health Organization; EMT; epithelial-to-mesenchymal; DAB; diaminobenzidine; FBS; Fetal Bovine Serum; IDH1-wt; wild type IDH1; IDH1-mut; IDH1-R132H
IDH1, lipid metabolism and cancer: Shedding new light on old ideas
Keywords: IDH1; isocitrate dehydrogenase 1; AML; acute myelogenous leukemia; PC; phosphatidylcholine; PE; phosphatidylethanolamine; PS; phosphatidylserine; PI; phosphatidylinositol; 2-HG; 2 hydroxyglutarate; RCDP; rhizomelic chondrodysplasia punctata; NADP; nicotin
IDH1R132H mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status
Keywords: Isocitrate dehydrogenase 1; IDH1; IDH1R132H; Glioma; Radiation; Hypoxia;
A high-sensitive HMab-2 specifically detects IDH1-R132H, the most common IDH mutation in gliomas
Keywords: IDH1; IDH1 mutation; R132H; Monoclonal antibody; HMab-2; IDH; isocitrate dehydrogenase; mAb; monoclonal antibody;
IDH1, a CHOP and C/EBPβ-responsive gene under ER stress, sensitizes human melanoma cells to hypoxia-induced apoptosis
Keywords: IDH1; ER stress; CHOP; HIF-1α; Apoptosis
Imaging Genomics of Glioblastoma
Keywords: Glioblastoma; Imaging genomics; Genetic biomarkers; Radiogenomics; MGMT; IDH1; EGFR; 1p/19q;
Mutation and expression analysis of the IDH1, IDH2, DNMT3A, and MYD88 genes in colorectal cancer
Keywords: CRC; colorectal cancer; APC; adenomatous polyposis coli; KRAS; Kirsten rat sarcoma viral oncogene homolog; TP53; tumor protein p53; IDH1; isocitrate dehydrogenase 1 (NADPÂ +), soluble; IDH2; isocitrate dehydrogenase 2 (NADPÂ +), mitochondrial; DNMT3A; DNA
Extracellular RNA mediates and marks cancer progression
Keywords: ASO, antisense oligonucleotides; CSF, cerebrospinal fluid; EGFR, epidermal growth factor receptor; ESCC, esophageal squamous cell cancer; EV, extracellular vesicle; exRNA, extracellular RNA; HDL, high-density lipoprotein; HLSC, human liver stem cell; IDH1
Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication
Keywords: Acadm; acyl-coenzyme A dehydrogenase medium chain; HCV; hepatitis C virus; Herc5; HECT and RLD domain containing E3 ubiquitin protein ligase 5; HnrnpA3; heterogeneous nuclear ribonucleoprotein A3; HnrnpK; heterogeneous nuclear ribonucleoprotein K; Hmgcs1;
Identification of proteomic signatures associated with lung cancer and COPD
Keywords: 2D-PAGE; Two dimensional electrophoresis; AKR1B10; Aldo-keto reductase family 1, member B10; AKR1C3; Aldo-keto reductase family 1, member C3; ALDH3A1; Aldehyde dehydrogenase 3 family, member A1; ALDOA; Aldolase A; AMY1A; Alpha 1 amylase; AMY2A; Alpha 2 am
A case of oligodendroglioma with prominent neuronal differentiation
Keywords: Oligodendroglioma; Gangliocytoma; Neurocytoma; Neuronal differentiation; IDH1
Genetics and pharmacogenomics of diffuse gliomas
Keywords: Companion diagnostics; Glioma; 1p/19q co-deletion; IDH1; Pharmacogenomics; EGFRvIII; CGH; comparative genomic hybridization; CNA; copy number aberrations; CRC; colorectal carcinoma; CML; chronic myeloid leukemia; EGFR; epidermal growth factor receptor; FF
IDH1 and IDH2 have critical roles in 2-hydroxyglutarate production in D-2-hydroxyglutarate dehydrogenase depleted cells
Keywords: D-2HGA; D-2-hydroxyglutaric aciduria; D-2HG; D-2-hydroxyglutarate; 2HG; 2-hydroxyglutarate; D2HGDH; D-2-hydroxyglutarate dehydrogenase; IDH1; isocitrate dehydrogenase 1; IDH2; isocitrate dehydrogenase 2; HOT; hydroxyacid oxoacid transhydrogenase; D-2-hydr
Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma
Keywords: Angiocentric glioma; IDH1; IDH1 R132H immunostain; mIDH1R132H